Cell Culture Market

The cell culture market is projected to reach USD 57.9 billion by 2029 from an estimated USD 30.9 billion in 2024, at a CAGR of 13.4% during the forecast period. The major factors driving the growth of this cell culture market include growing government support and fundings for cell-based research, rising adoption of single-use technologies, and increasing incidences of infectious diseases.

The global cell culture market is competitive with top players contributing for the major share including:

• Thermo Fisher Scientific Inc. (US),
• Danaher Corporation (US),
• Merck KGaA (Germany),
• Sartorius AG (Germany) and many more....

The market players have adopted various strategies such as new product launches, acquisitions, agreements, collaborations, and geographical expansions to strengthen their position in the global cell culture market.

To know about the assumptions considered for the study download the pdf brochure

Thermo Fisher Scientific Inc. (US):

Thermo Fisher Scientific is a leading provider of scientific solutions, offering a diverse range of products in the cell culture market, including cell culture media, reagents, supplements, and advanced technologies for cell growth and maintenance, enabling researchers to achieve optimal results in their experiments and bioproduction processes. Its leading position is attributed to its strong brand image and robust product portfolio. The company offers its products through well-established brands such as Gibco, Nunc, Countess, Dynabeads, and HyPerforma. It has focused on product launches, expansions, and acquisitions in the last three years. For example, in September 2022, Thermo Fisher Scientific launched the DynaSpin Single-Use Centrifuge System, a new technology that enables efficient cell culture harvesting while reducing the usage of traditional depth filtration.

Danaher Corporation (US):

Danaher Corporation is a leading life sciences and diagnostics innovator providing a wide range of products and services for medical, industrial, and commercial applications. With this strong global presence, Danaher Corporation is constantly involved in acquisitions and partnerships. For instance, in October 2022, Cytiva acquired CEVEC Pharmaceuticals. This acquisition strengthened Cytiva’'s position in biomanufacturing solutions and allows its customers to have immediate access to technologies. Additionally, the company emphasizes on expanding its capabilities in the cell culture market. For Instance, in September 2023, Cytiva expanded its facility with the establishment of a new Center of Excellence for single-use technologies in Shanghai. This facility is designed to help advance and accelerate the development of novel therapeutics.

Meck KGaA (Germany):

Merck KGaA offers a wide range of cell culture products, including media, sera, supplements, and reagents, catering to various research, bioprocessing, and clinical applications. They are widely used in biopharmaceutical manufacturing. The company has a strong international presence, with a wide distribution network and established relationships with research institutions, and biotechnology & pharmaceutical companies worldwide. Merck focuses on expanding its presence in emerging markets due to the growing demand for cell culture products. This involves establishing partnerships, distribution networks, and manufacturing facilities in regions such as Asia -Pacific and Latin America. For instance, in April 2022, Merck entered into an agreement with the Administrative Management Committee of Wuxi National High-Tech Industrial Development Zone. This development enabled Merck’s first-ever expansion of the Asia Pacific Mobius Single-use manufacturing center in China.

Related Reports:

Cell Culture Market by Product (Consumables (Media, Sera, Reagents), Vessels (Roller Bottle, Cell Factory, Flask), Equipment (SU Bioreactor, Storage, Incubators, Filtration)), Application (mAbs, Vaccines, Regenerative Medicine) - Global Forecast to 2029

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]